Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models (Q35796571)

10 August 2017

1 reference

title

Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models (English)

1 reference

10 August 2017

0 references

0 references

Gavin P Reynolds

1

1 reference

10 August 2017

Zuhal Abdul-Monim

series ordinal

2

1 reference

10 August 2017

Joanna C Neill

series ordinal

3

1 reference

10 August 2017

Zhi-Jun Zhang

series ordinal

4

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

Neurotoxicity Research

1 reference

10 August 2017

6

1 reference

10 August 2017

1

1 reference

10 August 2017

57-61

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033297

10 August 2017

0 references

cites work

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

1 reference

https://api.crossref.org/works/10.1007%2FBF03033297

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033297

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033297

Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033297

GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia

21 January 2018

1 reference

12 December 2020

Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain.

1 reference

12 December 2020

Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins

1 reference

12 December 2020

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

1 reference

12 December 2020

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

1 reference

12 December 2020

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

1 reference

12 December 2020

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

1 reference

12 December 2020

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.

1 reference

12 December 2020

Ontogeny of the calcium binding protein parvalbumin in the rat nervous system

1 reference

12 December 2020

Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain

1 reference

12 December 2020

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

1 reference

12 December 2020

A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.

1 reference

12 December 2020

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

1 reference

12 December 2020

A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia

1 reference

12 December 2020

Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033297

1 reference

10 August 2017

1 reference